Liver X receptors as potential therapeutic targets for multiple diseases

被引:28
作者
Cao, GQ [1 ]
Liang, Y
Jiang, XC
Eacho, PI
机构
[1] Eli Lilly & Co, Lilly Res Labs, Div Cardiovasc Discovery, Indianapolis, IN 46285 USA
[2] SUNY Downstate Med Ctr, Brooklyn, NY USA
关键词
D O I
10.1358/dnp.2004.17.1.829024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liver X receptor alpha (LXRalpha) and liver X receptor beta (LXRbeta) are oxysterol receptors that regulate multiple target genes involved in cholesterol homeostasis. Recent studies also suggest that the pair of receptors may also be involved in glucose metabolism, inflammation and Alzheimer's disease by regulating critical molecules involved in these pathophysiological processes. Although the prototypic LXR agonists induce liver triglyceride accumulation by regulating the hepatic lipogenesis pathway, it is hoped that a subtype-specific agonist or selective modulators would provide the desired cardioprotection and other benefits without the undesirable concomitant induction of lipogenesis. This review intends to summarize the most recent progress in the field and provide an assessment of LXRs as potential therapeutic targets. (C) 2004 Prous Science. All rights reserved.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 70 条
[1]   Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations [J].
Basso, F ;
Freeman, L ;
Knapper, CL ;
Remaley, A ;
Stonik, J ;
Neufeld, EB ;
Tansey, T ;
Amar, MJA ;
Fruchart-Najib, J ;
Duverger, N ;
Santamarina-Fojo, S ;
Brewer, HB .
JOURNAL OF LIPID RESEARCH, 2003, 44 (02) :296-302
[2]   Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice [J].
Bécard, D ;
Hainault, I ;
Azzout-Marniche, D ;
Bertry-Coussot, L ;
Ferré, P ;
Foufelle, F .
DIABETES, 2001, 50 (11) :2425-2430
[3]   Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters [J].
Berge, KE ;
Tian, H ;
Graf, GA ;
Yu, LQ ;
Grishin, NV ;
Schultz, J ;
Kwiterovich, P ;
Shan, B ;
Barnes, R ;
Hobbs, HH .
SCIENCE, 2000, 290 (5497) :1771-1775
[4]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[5]   A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood [J].
Brown, MS ;
Goldstein, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11041-11048
[6]   Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis [J].
Cao, GQ ;
Liang, Y ;
Broderick, CL ;
Oldham, BA ;
Beyer, TP ;
Schmidt, RJ ;
Zhang, YY ;
Stayrook, KR ;
Suen, C ;
Otto, KA ;
Miller, AR ;
Dai, JN ;
Foxworthy, P ;
Gao, H ;
Ryan, TP ;
Jiang, XC ;
Burris, TP ;
Eacho, PI ;
Etgen, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :1131-1136
[7]   Phospholipid transfer protein is regulated by liver X receptors in vivo [J].
Cao, GQ ;
Beyer, TP ;
Yang, XP ;
Schmidt, RJ ;
Zhang, YY ;
Bensch, WR ;
Kauffman, RF ;
Gao, H ;
Ryan, TP ;
Liang, Y ;
Eacho, PI ;
Jiang, XC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39561-39565
[8]   Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines [J].
Collins, JL ;
Fivush, AM ;
Watson, MA ;
Galardi, CM ;
Lewis, MC ;
Moore, LB ;
Parks, DJ ;
Wilson, JG ;
Tippin, TK ;
Binz, JG ;
Plunket, KD ;
Morgan, DG ;
Beaudet, EJ ;
Whitney, KD ;
Kliewer, SA ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) :1963-1966
[9]  
Costet P, 2000, J BIOL CHEM, V275, P28240
[10]  
DEMATTOS RB, 2002, SOC NEUR ABSTR, V32, P723